PHOENIX, Jan. 3, 2019 /PRNewswire-PRWeb/ -- CompanionCBD is excited to announce its line of easy to administer and
CompanionCBD was founded by Josh Sosnow and Brad Malin. Sosnow has been a practicing veterinarian in small animal medicine and surgery for over 18 years and is also the owner of North Scottsdale Animal Hospital and Desert View Animal Hospital, both located in located in Scottsdale, Ariz. Sosnow's business partner, Malin, is an entrepreneur, with over 21 years of experience in the medical distribution arena. Malin is also the founder of MB Health Partners, LLC, a global medical device distribution and consulting firm.
"With our veterinary patients, mainly dogs and cats, we have begun to use CBD to manage anxiety and behavioral disorders, with an ever-increasing measure of success Recent data also shows it can work to manage pain, osteoarthritis, diseases of the immune system, and seizure disorders," says Sosnow, the chief medical officer of CompanionCBD.
According to analysts at Brightfield Group, a CBD marketing and research company, CBD is expected to be a $22 billion industry by 2022. A 2018 study from Surgical Neurology International states that CBD has been reported to show numerous therapeutic properties in both animals and humans, including anxiolytic, antidepressant, neuroprotective, anti-inflammatory and immunomodulatory benefits. CompanionCBD also offers the latest research about CBD for pets and humans on its website, companioncbd.com/research.
"We knew that Daisy was slowing down. As an eleven-year-old golden, we figured that this was just going to be her new normal. However, after we started using Companion CBD's soft chews, we were stunned. Daisy could enjoy her walks again with renewed vigor! We thought she was just getting old, but now we realize it was her arthritis all along. Companion CBD's soft chews gave her a second chance at enjoying life," says dog owner, Mary Sprouse.
Unlike some of the more commonly used medications to manage anxiety and stress, CBD does not require regular dosing to be effective. Administration of CBD is effective and active within several hours of giving it to a pet. Due to the elasticity in dosing, a trial with CBD may be appropriate in order to determine the most effective dose for your pet. CBD can be used in both cats and dogs. CompanionCBD's soft chew CBD infused treats are available in different doses for pets from 15 pounds to 120 pounds.
CompanionCBD's products come in three different options: Companion Soft Chew- CBD Only, Companion Soft Chew for Osteoarthritis and Companion Soft Chew for Anxiety. The Companion Soft Chew- CBD Only promotes overall wellness in companion animals of all sizes. The Companion Soft Chew for Osteoarthritis combines pure CBD, Omega 3 EFA's and the anti-inflammatory compound, Palmitoylethanolamide (PEA) to enhance effectiveness in managing osteoarthritis in pets. Lastly, the Companion Soft Chew for Anxiety combines pure CBD with natural anti-anxiety supplements, Alpha-Casozepine and L-Theanine, to provide your pet relief from anxiety and other behavioral disorders.
The products are available wholesale through their online registration form and can also be found at participating retail locations. For more information, visit companioncbd.com.
About CompanionCBD CompanionCBD was founded with a simple idea in mind: CBD products can be a valuable complementary therapy in managing a wide range of diseases, but only if they're cost-effective, easy-to-administer at correct doses and be palatable to both people and pets. CompanionCBD's range of products does just that. For more information, visit companioncbd.com.
Subscribe to our Free Newsletters!